Search for: "Sanofi-Aventis US Inc" Results 121 - 140 of 160
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous… [read post]
3 Aug 2011, 3:31 am by Marie Louise
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs)   Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin… [read post]
16 Jan 2009, 7:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
18 Jul 2014, 11:55 am
  Gasguzzlers ‘R Us didn’t get its federal bailout and goes bankrupt. [read post]
2 Dec 2011, 2:00 pm by Bexis
Sanofi-Aventis United States LLC, 2011 WL 3666595, at *3 (W.D. [read post]
14 May 2015, 4:00 am by Paula Bremner
The Court construed Sanofi’s selection patent and found there was no “promise for use in humans”. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
11 Jan 2008, 9:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]Highlights this week included: European Commission launches consultation on ‘Content Online in the Single Market': (IPKat), (Out-Law), (IPR Helpdesk), UK government launches consultation on copyright exceptions: (IPKat), (Michael Geist), (IMPACT), (Patry Copyright Blog), (Out-Law), (Ars Technica), (IP Law360), Cordis Corporation - US Court of… [read post]
14 Jan 2021, 4:40 pm by anne
Nearly $200 million in recoveries against pharmaceutical companies Gilead, Novartis, and Sanofi-Aventis as well as several patient assistance foundations resolving claims that the drug companies illegally paid patient copays for their own drugs through the purportedly independent foundations that were actually treated as mere conduits for these payments. [read post]
9 Aug 2008, 1:50 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
23 Dec 2007, 8:00 pm
: (IPKat),Spare part design protection: the European Parliament's view: (IPKat), (Catch us if you can)Cyprus fails to delight Turkey -  Cyprus is to gain PGI recognition for Turkish delight: (IPKat),Mewsings on the word ‘technical' (What does the EPO mean when it uses the word ‘technical'?) [read post]